Match tier
Confirmed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-10
P
Praveen R. Juvvadi
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
Also affiliated: Duke University (2011–2025); Duke Medical Center (2008–2025); Arkansas Children's Research Institute (2022–2026); The University of Tokyo (2001–2010)
39 h-index
96 pubs
5,443 cited
Biomedical Subjects
Links
Biography and Research Information
Metrics
- h-index: 39
- Publications: 96
- Citations: 5,443
Positions
-
Associate Professor 2022–presentUniversity of Arkansas for Medical Sciences Pediatrics - Infectious Diseases ORCID
-
Associate Professor 2020–2022Duke Medical Center Pediatric Infectious Diseases ORCID
-
Assistant Professor 2012–2020Duke Medical Center Pediatric Infectious Diseases ORCID
-
Research Scientist 2010–2012Duke Medical Center Pediatric Infectious Diseases ORCID
-
Senior Research Associate 2008–2010Duke Medical Center Pediatric Infectious Diseases ORCID
-
Instructor 2007Bharat Institute of Engineering and Technology Biotechnology ORCID
-
Visiting Research Scientist 2006–2007University of Tokyo Biotechnology ORCID
-
Research Associate (BRAIN) 2003–2006University of Tokyo Biotechnology ORCID
-
Research Investigator (MECD) 2002University of Seville Genetics ORCID
-
Postdoctoral Fellow (JSPS) 1999–2001University of Tokyo Biotechnology ORCID
Selected Publications
-
Multifunctional Roles of Autophagy in Fungi (2026)
-
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi (2024)
-
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi (2024)
-
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal (2023)
-
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22-modified FK520 analog against C. neoformans (2023)
-
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans (2023)
-
Calcineurin Inhibitor CN585 Exhibits Off-Target Effects in the Human Fungal Pathogen Aspergillus fumigatus (2022)